Brief: Volitionrx Limited Executes A Contract For Clinical Trial Program In Lung Cancer
07/05/2019 13:44
May 7 (Reuters) - VolitionRX Ltd VNRX.A :
* VOLITIONRX LIMITED EXECUTES A CONTRACT FOR CLINICAL TRIAL
PROGRAM IN LUNG CANCER
Source text for Eikon: ID:nPn2C500la
Further company coverage: VNRX.A
(Reuters.Briefs@thomsonreuters.com)
Recent news on VolitionRX
See all newsBrief: Volitionrx -Files Preliminary Prospectus For 10,006,360 Shares Of Common Stock Offered By Selling Stockholder - SEC Filing
Brief: Volitionrx - Advances Nu.Q Nets Platform Towards Commercialization
Brief: VolitionRX Limited Announces First Quarter 2026 Financial Results
Brief: Volition Reports Breakthrough In Liquid Biopsy Achievement Of Over 99% Purity In Isolating Cancer Dna
Brief: Volition Announces First Ever Automated Nu.Q® Vet Cancer Test With Fujifilm Vet Systems